TR199903095T2 - Diabetin roziglitazon ve ins�lin ile tedavisi. - Google Patents

Diabetin roziglitazon ve ins�lin ile tedavisi.

Info

Publication number
TR199903095T2
TR199903095T2 TR1999/03095T TR9903095T TR199903095T2 TR 199903095 T2 TR199903095 T2 TR 199903095T2 TR 1999/03095 T TR1999/03095 T TR 1999/03095T TR 9903095 T TR9903095 T TR 9903095T TR 199903095 T2 TR199903095 T2 TR 199903095T2
Authority
TR
Turkey
Prior art keywords
insulin
rosiglitazone
diabetes
treatment
diabetes mellitus
Prior art date
Application number
TR1999/03095T
Other languages
English (en)
Turkish (tr)
Inventor
Alistair Smith Stephen
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR199903095T2 publication Critical patent/TR199903095T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR1999/03095T 1997-06-18 1998-06-15 Diabetin roziglitazon ve ins�lin ile tedavisi. TR199903095T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9712866.4A GB9712866D0 (en) 1997-06-18 1997-06-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR199903095T2 true TR199903095T2 (xx) 2000-08-21

Family

ID=10814527

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03095T TR199903095T2 (xx) 1997-06-18 1998-06-15 Diabetin roziglitazon ve ins�lin ile tedavisi.

Country Status (30)

Country Link
EP (1) EP0999837A1 (xx)
JP (1) JP2002504138A (xx)
KR (1) KR20010013843A (xx)
CN (1) CN1133431C (xx)
AP (1) AP1287A (xx)
AR (2) AR015894A1 (xx)
AU (1) AU8216398A (xx)
BG (1) BG104059A (xx)
BR (1) BR9810444A (xx)
CA (1) CA2294141A1 (xx)
CO (1) CO4940454A1 (xx)
DZ (1) DZ2521A1 (xx)
EA (1) EA004800B1 (xx)
GB (1) GB9712866D0 (xx)
HU (1) HUP0003260A3 (xx)
ID (1) ID23951A (xx)
IL (1) IL133143A0 (xx)
IN (1) IN189723B (xx)
MA (1) MA26511A1 (xx)
NO (1) NO996265D0 (xx)
OA (1) OA11517A (xx)
PE (1) PE104499A1 (xx)
PL (1) PL343123A1 (xx)
SK (1) SK179399A3 (xx)
TR (1) TR199903095T2 (xx)
TW (1) TW587937B (xx)
UA (1) UA70299C2 (xx)
UY (1) UY25050A1 (xx)
WO (1) WO1998057636A1 (xx)
ZA (1) ZA985237B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291495B1 (en) * 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
BR0009934A (pt) 1999-04-23 2002-06-04 Smithkline Beecham Plc Produto farmacêutico
EP1849475A1 (en) * 1999-06-21 2007-10-31 Eli Lilly & Company Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
WO2001000223A2 (en) * 1999-06-25 2001-01-04 Minimed Inc. Multiple agent diabetes therapy
US6468507B1 (en) * 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
WO2002067969A2 (en) 2001-02-21 2002-09-06 Medtronic Minimed, Inc. Stabilized insulin formulations
US6531461B1 (en) 2001-06-04 2003-03-11 Louis Obyo Obyo Nelson Medicament for the treatment of diabetes
US20020198203A1 (en) * 2001-06-07 2002-12-26 Wyeth Combination of a PTPase inhibitor and a thiazolidinedione agent
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
DE60317365T2 (de) 2002-11-08 2008-08-21 F. Hoffmann-La Roche Ag Substituierte 4-alkoxyoxazol derivate als ppar agonisten
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102389427A (zh) * 2011-10-10 2012-03-28 成都恒瑞制药有限公司 含有罗格列酮和盐酸西替利嗪的固体口服制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE376829T1 (de) * 1993-09-15 2007-11-15 Daiichi Sankyo Co Ltd Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm)
WO1997005875A2 (en) * 1995-08-10 1997-02-20 Warner-Lambert Company A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
KR19990045756A (ko) * 1995-09-18 1999-06-25 윌리암 엘. 레스페스 Ｒｘｒ 작용제를 이용하는 ｎｉｄｄｍ 치료 방법

Also Published As

Publication number Publication date
CN1133431C (zh) 2004-01-07
TW587937B (en) 2004-05-21
AR015894A1 (es) 2001-05-30
KR20010013843A (ko) 2001-02-26
IN189723B (xx) 2003-04-19
EP0999837A1 (en) 2000-05-17
JP2002504138A (ja) 2002-02-05
NO996265L (no) 1999-12-17
WO1998057636A1 (en) 1998-12-23
SK179399A3 (en) 2000-11-07
BG104059A (en) 2000-10-31
HUP0003260A2 (hu) 2001-05-28
ZA985237B (en) 2000-02-17
UY25050A1 (es) 2000-09-29
AU8216398A (en) 1999-01-04
HUP0003260A3 (en) 2001-12-28
PL343123A1 (en) 2001-07-30
PE104499A1 (es) 2000-01-13
AR012997A1 (es) 2000-11-22
EA004800B1 (ru) 2004-08-26
ID23951A (id) 2000-06-08
AP9901718A0 (en) 1999-12-31
AP1287A (en) 2004-06-26
OA11517A (en) 2004-02-04
EA200000042A1 (ru) 2000-08-28
CO4940454A1 (es) 2000-07-24
NO996265D0 (no) 1999-12-17
BR9810444A (pt) 2000-09-05
UA70299C2 (en) 2004-10-15
MA26511A1 (fr) 2004-12-20
CN1260715A (zh) 2000-07-19
GB9712866D0 (en) 1997-08-20
DZ2521A1 (fr) 2003-02-08
IL133143A0 (en) 2001-03-19
CA2294141A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
TR199903057T2 (xx) Diabetin tiazolidinedion ve metformin ile tedavisi.
TR199903095T2 (xx) Diabetin roziglitazon ve ins�lin ile tedavisi.
CY1105254T1 (el) Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο
EA200300036A1 (ru) Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета
EA200101089A1 (ru) Новый способ лечения
WO2001091774A3 (en) Method of treating chronic ulcers
NO20083276L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
TR199903072T2 (xx) Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi.
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
TR200000135T2 (tr) Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
EA200700968A1 (ru) Фармацевтическая композиция для лечения сахарного диабета 2 типа
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
NZ503862A (en) Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia
HUP0002669A2 (hu) Diabetes kezelése dioxo-tiazolidinnel és szulfonil-karbamiddal
HUP0002569A2 (hu) Diabetes kezelésére alkalmas dioxo-tiazolidint és alfa-glükozidáz inhibitort tartalmazó gyógyszerkészítmények
ECSP982541A (es) Nuevo metodo de tratamiento ii